Related Experiment Video
Updated: Jun 16, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Diagnostic delay in inflammatory bowel diseases in a German population
Elisabeth Blüthner1, Annalena Dehe1,2, Carsten Büning1,3
1Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin 10117, Germany.
Crohn's disease patients experience significantly longer diagnostic delays than ulcerative colitis patients, primarily due to extended physician diagnostic times. Identifying risk factors for delayed diagnosis in inflammatory bowel disease (IBD) is crucial for timely treatment.
Area of Science:
- Gastroenterology
- Internal Medicine
- Clinical Research
Background:
- Early diagnosis of inflammatory bowel disease (IBD) is critical for preventing bowel damage.
- Limited data exists on risk factors for delayed IBD diagnosis in European populations, with no specific data for German patients.
Purpose of the Study:
- To identify risk factors associated with prolonged diagnostic timelines in a cohort of German IBD patients.
- To differentiate diagnostic delays between Crohn's disease (CD) and ulcerative colitis (UC).
Main Methods:
- A prospective study involving 430 IBD patients from four Berlin hospitals between 2012 and 2022.
- Patients completed a questionnaire to detail their diagnostic journey, including patient and physician waiting times.
- Univariate and multivariate analyses were used to determine risk factors for diagnostic delays.
Main Results:
- Total diagnostic time was substantially longer for Crohn's disease (CD) patients compared to ulcerative colitis (UC) patients (12.0 vs. 4.0 months).
- Predominant symptoms like diarrhea and skin lesions, along with gastroscopy, were linked to longer physician diagnostic times in CD.
- Fever correlated with shorter physician diagnostic time in UC, while fatigue and family history were associated with longer delays.
Conclusions:
- Crohn's disease patients face a higher risk of diagnostic delay compared to UC patients.
- Targeted interventions to shorten the diagnostic delay are essential for improving patient outcomes in IBD.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Serum Laboratory Studies, Stool Test, Breath Test
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

